Cardiotoxicity of chemicals: Current regulatory guidelines, knowledge gaps, and needs
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Bopp, S. K., Kienzler, A., Richarz, A. N. et al. (2019). Regulatory assessment and risk management of chemical mixtures: challenges and ways forward. Crit Rev Toxicol, 49(2), 174-189. doi:10.1080/10408444.2019.1579169
Burnett, S. D., Blanchette, A. D., Chiu, W. A. and Rusyn, I. (2021). Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple Donors. Chem Res Toxicol, 34(9), 2110-2124. doi:10.1021/acs.chemrestox.1c00203
Daley, M. C., Mende, U., Choi, B. R. et al. (2022). Beyond pharmaceuticals: Fit-for-purpose new approach methodologies for environmental cardiotoxicity testing. ALTEX. doi:10.14573/altex.2109131
ECHA, E. C. A. (2017). Guidance on the Biocidal Products Regulation: Volume III Human Health-Assessment & Evaluation (Parts B+C). Retrieved 9 Nov, 2022 from
EU (2006). REGULATION (EC) No 1907/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006. Retrieved Sept. 1, 2022 from https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:136:0003:0280:en:PDF
EU (2009). REGULATION (EC) No 1107/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 21 October 2009. Retrieved Sept. 1, 2022 from https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:309:0001:0050:EN:PDF
EU (2012). REGULATION (EU) No 528/2012 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 May 2012. Retrieved Sept. 1, 2022 from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32012R0528
Kemikalieinspektionen (2021). PM 8/21: Improving the regulatory assessment of combination effects: steps towards implementing the mixture assessment factor (MAF) in chemical regulation. Retrieved 25th November 2022 from https://www.kemi.se/publikationer/pm/2021/pm-8-21-improving-the-regulatory-assessment-of-combination-effects-steps-towards-implementing-the-mixture-assessment-factor-maf-in-chemical-regulation
Krishna, S., Berridge, B. and Kleinstreuer, N. (2021). High-Throughput Screening to Identify Chemical Cardiotoxic Potential. Chem Res Toxicol, 34(2), 566-583. doi:10.1021/acs.chemrestox.0c00382
OECD (2017). CHEMICAL SAFETY ASSESSMENT WORKFLOW BASED ON EXPOSURE CONSIDERATIONS AND NON-ANIMAL METHODS. Series on Testing and Assessment, No. 275.
OECD (2022). OECD Test Guidelines for Chemicals - OECD. Retrieved Jul. 05, 2022 from https://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm
Paparella, M., Bennekou, S. H. and Bal-Price, A. (2020). An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches. Reprod Toxicol, 96, 327-336. doi:10.1016/j.reprotox.2020.08.002
Paparella, M., Colacci, A. and Jacobs, M. N. (2017). Uncertainties of testing methods: What do we (want to) know about carcinogenicity? ALTEX 34, 235-252. doi:10.14573/altex.1608281
WHO – World Health Organization (2018). Guidance Document on Evaluating and Expressing Uncertainty in Hazard Characterization The International Programme on Chemical Safety. https://www.who.int/publications/i/item/9789241513548